Onconetix (ONCO) Competitors

Talphera (NASDAQ:TLPH) and Onconetix (NASDAQ:ONCO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk, institutional ownership and media sentiment.

Does the media refer more to TLPH or ONCO?

In the previous week, Onconetix had 5 more articles in the media than Talphera. MarketBeat recorded 6 mentions for Onconetix and 1 mentions for Talphera. Talphera's average media sentiment score of 1.89 beat Onconetix's score of 0.32 indicating that Talphera is being referred to more favorably in the media.

Company	Overall Sentiment
Talphera	Very Positive
Onconetix	Neutral

Which has preferable earnings & valuation, TLPH or ONCO?

Talphera has higher earnings, but lower revenue than Onconetix.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Talphera	$650K	13.56	-$13M	-$0.45	-0.96
Onconetix	$2.52M	0.74	-$58.69M	N/A	N/A

Do insiders & institutionals have more ownership in TLPH or ONCO?

37.7% of Talphera shares are owned by institutional investors. Comparatively, 23.9% of Onconetix shares are owned by institutional investors. 3.2% of Talphera shares are owned by company insiders. Comparatively, 3.1% of Onconetix shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Is TLPH or ONCO more profitable?

Talphera has a net margin of 0.00% compared to Onconetix's net margin of -2,913.71%. Talphera's return on equity of -130.28% beat Onconetix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Talphera	N/A	-130.28%	-59.25%
Onconetix	-2,913.71%	-514.04%	-75.82%

Which has more volatility and risk, TLPH or ONCO?

Talphera has a beta of -0.11, suggesting that its share price is 111% less volatile than the S&P 500. Comparatively, Onconetix has a beta of 3.38, suggesting that its share price is 238% more volatile than the S&P 500.

Do analysts rate TLPH or ONCO?

Talphera currently has a consensus price target of $5.00, indicating a potential upside of 1,062.79%. Given Talphera's stronger consensus rating and higher possible upside, analysts plainly believe Talphera is more favorable than Onconetix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Talphera	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	3.50
Onconetix	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Talphera beats Onconetix on 12 of the 15 factors compared between the two stocks.